Thursday’s insider activity: Notable buys at Agora and Rapport

Insider activity reported for several US public companies. Agora's CEO bought $168,304 in shares, Rapport Therapeutics saw two directors buy shares totaling $346,168, Corebridge Financial's 10% owner bought $6.77M, and BNY Mellon Strategic Municipals had a director buy $262,611. Sells included United Therapeutics' CEO selling $5.32M, Innsuites' CEO selling $2.01B, Arista Networks' CTO selling $7.84M, Lindblad Expeditions' director selling $8.64M, and Braze's CTO selling $13.22M.

Original reporting
Published Oct 23, 2026, 1:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 1:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$API
Bullish
medium confidence
Mentioned
$API · $RAPP · $CRBG · $LEO · $UTHR · $IHT
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$APIBullishLow
01

Why it matters

Overall, the roundup provides limited actionable insight; individual insider buys may offer modest upside, while sizable sells could pressure specific stocks.

02

Market read

Insider activity is a standard market signal; the mixed nature of buys and sells yields low overall trading relevance.

03

What to watch

Many purchases are via 10b5‑1 plans, which may be pre‑scheduled and not reflect current sentiment.

Relevance 4/10Novelty 3/10Timing: today

Background

The article aggregates recent Form 4 insider transactions reported on Thursday, covering both purchases and sales across multiple U.S. listed companies.

Company-level read

Ticker impact

$APIBullishMedium confidence
Context

CEO Zhao Bin bought 38,267 ADS of Agora (API) via 10b5‑1 plan, indicating insider confidence as stock nears $4.39.

Expected impact

likely upward pressure from perceived confidence

Evidence & confidence

Insider purchase size is modest relative to market cap; may attract short‑term buyers.

$RAPPBullishMedium confidence
Context

Directors Paul Steven M. and John Maraganore purchased shares of Rapport Therapeutics (RAPP) totaling over $1.2 M, showing insider support despite a 27% six‑month decline.

Expected impact

upward pressure from insider buying

Evidence & confidence

Multiple insider purchases within a day suggest belief in near‑term upside.

$CRBGBullishMedium confidence
Context

Nippon Life Insurance, a 10% owner, bought $6.77 M of Corebridge Financial (CRBG) shares via 10b5‑1 plan, near 52‑week high.

Expected impact

likely supportive to price, modest upside

Evidence & confidence

Large strategic investor purchase reinforces confidence in valuation.

$LEONeutralLow confidence
Context

Saba Capital Management acquired 45,831 shares of BNY Mellon Strategic Municipals (LEO) for $262,611, indicating institutional interest.

Expected impact

minimal price effect, possible slight upside

Evidence & confidence

Purchase size is small relative to float; unlikely to move price materially.

$UTHRBearishMedium confidence
Context

United Therapeutics CEO Martine Rothblatt sold $5.32 M of shares via 10b5‑1 plan, near 52‑week high.

Expected impact

downward pressure as market absorbs sell signal

Evidence & confidence

Large insider sell at high valuation may raise concerns.

$IHTBearishHigh confidence
Context

President/CEO James Wirth sold 43,111 shares of Innsuites Hospitality Trust (IHT) for $2.01 B, indicating major insider divestment.

Expected impact

likely downward pressure

Evidence & confidence

Massive insider sell suggests lack of confidence; could trigger broader sell‑off.

$ANETBearishLow confidence
Context

Arista Networks CTO Kenneth Duda sold $7.84 M of shares via 10b5‑1 plan, coinciding with a recent price dip.

Expected impact

slight downward pressure

Evidence & confidence

Sell size modest relative to market; limited impact.

$LINDBearishLow confidence
Context

Director Sven‑Olof Lindblad sold 240,965 shares of Lindblad Expeditions (LIND) for $8.64 M near 52‑week high.

Expected impact

possible slight downside

Evidence & confidence

Insider sell may temper momentum but size is not large enough for major move.

Market effects

Insider activity across diverse sectors (tech, biotech, REITs) may signal broader confidence trends but no sector-wide catalyst.

Primarily U.S. equities; limited cross‑regional effect.

Low global relevance; impacts confined to individual stocks.

Counterpoint

Large insider sells (e.g., IHT, BRZE) could indicate overvaluation and present buying opportunities on pullbacks.

Key entities

  • Zhao Bin

    CEO of Agora, insider buyer

  • Paul Steven M.

    Director of Rapport Therapeutics, insider buyer

  • Martine Rothblatt

    CEO of United Therapeutics, insider seller

Related articles

$APIMedAI 8/10

Agora Inc (API) Q3 2026 Earnings Call Transcript

Agora Inc (API) reported Q3 2026 revenue of $42.1M, up 19% YoY, driven by real-time engagement and conversational AI products. Gross margin was 63.4%, down YoY due to product mix. The company highlighted advancements in AI interaction technology and plans to expand AI product deployment. GAAP net income was $3M, with $353M in cash reserves.

$APIMedAI 9/10

Agora, Inc. (API): Financial results for Q3 2026

Agora, Inc. (API) furnished an SEC Form 6-K — earnings release. Agora, Inc. Reports Third Quarter 2026 Financial Results SANTA CLARA, Calif., November 16, 2026 (GLOBE NEWSWIRE) -- Agora, Inc. (NASDAQ: API) (the “Company”), a pioneer and leader in conversational AI and real-time engagement technology, today announced its unaudited financial re

$CIENMed

Vistance Networks, Ciena, Arista Networks, Applied Digital, and CoreWeave shares are falling, what you need to know

Several enterprise networking stocks fell after the U.S. Commerce Department closed a loophole allowing Chinese companies to lease Nvidia computing power, compounding market concerns. Vistance Networks, Ciena, Arista Networks, Applied Digital, and CoreWeave shares declined 5.4% to 8.9%. UBS lowered Nvidia's price target to $240 from $300, citing potential export curbs. Applied Digital's shares are down 48.3% year-to-date, trading 70.7% below its 52-week high.